Skip to content
← Full study record

NCT00112723 · MORE INFO

Limitations, agreements, and source contact

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma · Source last updated 2016-08-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
Jeffrey.Jones@osumc.edu
organization
The Ohio State University Comprehensive Cancer Center
phone
614-293-3507
title
Jeffrey Jones, MD
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
Jeffrey.Jones@osumc.edu
organization
The Ohio State University Comprehensive Cancer Center
phone
614-293-3507
title
Jeffrey Jones, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice